API australian pharmaceutical industries limited

share price, page-4

  1. 2,000 Posts.
    lightbulb Created with Sketch. 27
    API have been on the nose now for about a year - mostly due to the (unfounded) panic of Amazon entering the market, but also because the industry has pretty low hurdles to competition. Metrics aren't all that compelling, but not bad either, so its mainly emotion that wins out. I suspect it will drift lower before finding a floor - probably above $1, though.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.